FDA — authorised 19 December 1996
- Status: approved
🇺🇸 Sparcin in United States
FDA authorised Sparcin on 19 December 1996
Marketing authorisations
FDA — authorised 19 December 1996
- Application: NDA020677
- Marketing authorisation holder: MYLAN
- Local brand name: ZAGAM
- Indication: TABLET — ORAL
- Status: approved
Sparcin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Sparcin approved in United States?
Yes. FDA authorised it on 19 December 1996; FDA authorised it on 19 December 1996.
Who is the marketing authorisation holder for Sparcin in United States?
Marketing authorisation holder not available in our data.